Analystreport

Nektar Therapeutics (NASDAQ: NKTR) is now covered by analysts at Leerink Swann. They set a "market perform" rating on the stock.

Nektar Therapeutics  (NKTR) 
Last nektar therapeutics earnings: 2/27 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.nektar.com/investor-relations